Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Association among Eslicarbazepine acetate on lipid metabolism and sodium values and to compare it with previous effects of traditional dibenzazepine drugs in patients with epilepsy

Trial Profile

Association among Eslicarbazepine acetate on lipid metabolism and sodium values and to compare it with previous effects of traditional dibenzazepine drugs in patients with epilepsy

Completed
Phase of Trial: Phase IV

Latest Information Update: 15 Nov 2017

At a glance

  • Drugs Eslicarbazepine acetate (Primary)
  • Indications Epilepsy
  • Focus Therapeutic Use
  • Most Recent Events

    • 15 Nov 2017 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top